291 related articles for article (PubMed ID: 35217794)
1. N
Chen B; Jiang W; Huang Y; Zhang J; Yu P; Wu L; Peng H
Oncogene; 2022 Apr; 41(15):2239-2253. PubMed ID: 35217794
[TBL] [Abstract][Full Text] [Related]
2. Aberrant translation regulated by METTL1/WDR4-mediated tRNA N7-methylguanosine modification drives head and neck squamous cell carcinoma progression.
Chen J; Li K; Chen J; Wang X; Ling R; Cheng M; Chen Z; Chen F; He Q; Li S; Zhang C; Jiang Y; Chen Q; Wang A; Chen D
Cancer Commun (Lond); 2022 Mar; 42(3):223-244. PubMed ID: 35179319
[TBL] [Abstract][Full Text] [Related]
3. METTL1/WDR4-mediated tRNA m
Wang Z; Yu P; Zou Y; Ma J; Han H; Wei W; Yang C; Zheng S; Guo S; Wang J; Liu L; Lin S
Oncogene; 2023 Jun; 42(23):1900-1912. PubMed ID: 37185458
[TBL] [Abstract][Full Text] [Related]
4. N
Dai Z; Liu H; Liao J; Huang C; Ren X; Zhu W; Zhu S; Peng B; Li S; Lai J; Liang L; Xu L; Peng S; Lin S; Kuang M
Mol Cell; 2021 Aug; 81(16):3339-3355.e8. PubMed ID: 34352206
[TBL] [Abstract][Full Text] [Related]
5. METTL1/WDR4-mediated m
Ma J; Han H; Huang Y; Yang C; Zheng S; Cai T; Bi J; Huang X; Liu R; Huang L; Luo Y; Li W; Lin S
Mol Ther; 2021 Dec; 29(12):3422-3435. PubMed ID: 34371184
[TBL] [Abstract][Full Text] [Related]
6. N
Han H; Yang C; Ma J; Zhang S; Zheng S; Ling R; Sun K; Guo S; Huang B; Liang Y; Wang L; Chen S; Wang Z; Wei W; Huang Y; Peng H; Jiang YZ; Choe J; Lin S
Nat Commun; 2022 Mar; 13(1):1478. PubMed ID: 35304469
[TBL] [Abstract][Full Text] [Related]
7. METTL1 promotes hepatocarcinogenesis via m
Chen Z; Zhu W; Zhu S; Sun K; Liao J; Liu H; Dai Z; Han H; Ren X; Yang Q; Zheng S; Peng B; Peng S; Kuang M; Lin S
Clin Transl Med; 2021 Dec; 11(12):e661. PubMed ID: 34898034
[TBL] [Abstract][Full Text] [Related]
8. Upregulated METTL3 in nasopharyngeal carcinoma enhances the motility of cancer cells.
Liu ZF; Yang J; Wei SP; Luo XG; Jiang QS; Chen T; Gong YQ
Kaohsiung J Med Sci; 2020 Nov; 36(11):895-903. PubMed ID: 32668092
[TBL] [Abstract][Full Text] [Related]
9. Rab1A promotes cancer metastasis and radioresistance through activating GSK-3β/Wnt/β-catenin signaling in nasopharyngeal carcinoma.
Yang XZ; Chen XM; Zeng LS; Deng J; Ma L; Jin C; Wang R; Wang MH; Wen YF; Wu XL; Wang HY; Cui SZ
Aging (Albany NY); 2020 Oct; 12(20):20380-20395. PubMed ID: 33068388
[TBL] [Abstract][Full Text] [Related]
10. Mettl1/Wdr4-Mediated m
Lin S; Liu Q; Lelyveld VS; Choe J; Szostak JW; Gregory RI
Mol Cell; 2018 Jul; 71(2):244-255.e5. PubMed ID: 29983320
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-215 promoted the progression of nasopharyngeal carcinoma through targeting RB1 and activating Wnt/β-catenin pathway.
Zhang Y; Zhang H; Li X
J BUON; 2020; 25(3):1579-1586. PubMed ID: 32862607
[TBL] [Abstract][Full Text] [Related]
13. WDR4 promotes HCC pathogenesis through N
Dong R; Wang C; Tang B; Cheng Y; Peng X; Yang X; Ni B; Li J
Cell Signal; 2024 Jun; 118():111145. PubMed ID: 38493882
[TBL] [Abstract][Full Text] [Related]
14. METTL1-mediated m
Orellana EA; Liu Q; Yankova E; Pirouz M; De Braekeleer E; Zhang W; Lim J; Aspris D; Sendinc E; Garyfallos DA; Gu M; Ali R; Gutierrez A; Mikutis S; Bernardes GJL; Fischer ES; Bradley A; Vassiliou GS; Slack FJ; Tzelepis K; Gregory RI
Mol Cell; 2021 Aug; 81(16):3323-3338.e14. PubMed ID: 34352207
[TBL] [Abstract][Full Text] [Related]
15. YPEL3 suppresses epithelial-mesenchymal transition and metastasis of nasopharyngeal carcinoma cells through the Wnt/β-catenin signaling pathway.
Zhang J; Wen X; Ren XY; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Sun Y; Liu N; Ma J
J Exp Clin Cancer Res; 2016 Jul; 35(1):109. PubMed ID: 27400785
[TBL] [Abstract][Full Text] [Related]
16. TIMELESS confers cisplatin resistance in nasopharyngeal carcinoma by activating the Wnt/β-catenin signaling pathway and promoting the epithelial mesenchymal transition.
Liu SL; Lin HX; Lin CY; Sun XQ; Ye LP; Qiu F; Wen W; Hua X; Wu XQ; Li J; Song LB; Guo L
Cancer Lett; 2017 Aug; 402():117-130. PubMed ID: 28583847
[TBL] [Abstract][Full Text] [Related]
17. METTL1-Mediated m7G tRNA Modification Promotes Lenvatinib Resistance in Hepatocellular Carcinoma.
Huang M; Long J; Yao Z; Zhao Y; Zhao Y; Liao J; Lei K; Xiao H; Dai Z; Peng S; Lin S; Xu L; Kuang M
Cancer Res; 2023 Jan; 83(1):89-102. PubMed ID: 36102722
[TBL] [Abstract][Full Text] [Related]
18. ZNF488 Enhances the Invasion and Tumorigenesis in Nasopharyngeal Carcinoma Via the Wnt Signaling Pathway Involving Epithelial Mesenchymal Transition.
Zong D; Yin L; Zhong Q; Guo WJ; Xu JH; Jiang N; Lin ZR; Li MZ; Han P; Xu L; He X; Zeng MS
Cancer Res Treat; 2016 Jan; 48(1):334-44. PubMed ID: 25779368
[TBL] [Abstract][Full Text] [Related]
19. Melatonin reverses nasopharyngeal carcinoma cisplatin chemoresistance by inhibiting the Wnt/β-catenin signaling pathway.
Zhang J; Xie T; Zhong X; Jiang HL; Li R; Wang BY; Huang XT; Cen BH; Yuan YW
Aging (Albany NY); 2020 Mar; 12(6):5423-5438. PubMed ID: 32203052
[TBL] [Abstract][Full Text] [Related]
20. MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma.
Bissey PA; Teng M; Law JH; Shi W; Bruce JP; Petit V; Tsao SW; Yip KW; Liu FF
BMC Cancer; 2020 Jun; 20(1):597. PubMed ID: 32586280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
